We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Several controversial healthcare issues are beginning to make headway in Congress, with drug importation, biodefense and National Institutes of Health (NIH) legislation taking important steps toward becoming law in the past week.